PRAXIS PRECISION MEDICINES, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $4.07M.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $1.12M, a 99.82% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $808.00K, a 301.99% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $560.00K, a 291.61% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $12.56M, a 501.10% increase from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $2.09M, a 1948.04% increase from fiscal 2023.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $102.00K.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $88.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $4.07M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.12M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $12.56M 10-K · filed 2026-02-19 | |
| 2025-09-30 | $808.00K 10-Q · filed 2025-11-05 | |
| 2025-03-31 | $560.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $2.09M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $201.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $4.00K 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $143.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $102.00K 10-K · filed 2026-02-19 | |
| 2023-09-30 | $1.00K 10-K · filed 2025-02-28 | |
| 2023-03-31 | $101.00K 10-K · filed 2025-02-28 | $577.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-05 | $809.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-09-30 | $409.00K 10-K · filed 2024-03-05 | $1.29M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $67.00K 10-K · filed 2024-03-05 | $1.19M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $333.00K 10-K · filed 2024-03-05 | $1.93M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $478.00K 10-K · filed 2023-02-07 | $2.45M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $309.00K 10-K · filed 2023-02-07 | $2.03M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $809.00K 10-K · filed 2023-02-07 | $1.75M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $851.00K 10-K · filed 2023-02-07 | |
| 2020-12-31 | $61.00K 10-K · filed 2022-02-28 | $88.00K 10-K · filed 2021-03-17 |
| 2020-09-30 | $27.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |